In vivo bypass of hemophila A coagulation defect by Factor XIIa implant

Article Abstract:

Administration of recombinant Factor VIIa and Factor IX can overcome the coagulation defects associated with Hemophilia A and B respectively. Researchers have developed a continuous regeneration of Factor VIIa, which had formerly exhibited too short a half-life for clinical use.

Coagulants, Coagulants (Materials)

---

Production of hepatitis B surface antigen in transgenic plants for oral immunization

Article Abstract:

The article presents data showing oral immunogenicity of recombinant hepatitis B surface antigen (HBsAg) in preclinical animal trials.

Product development, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Vaccines & Antigens for Human Use, Biological products exc. diagnostic, Hepatic Preparations, Biological products, Antiviral agents, Hepatitis

---

In vitro selection of necleoprotein enzymes

Article Abstract:

Nucleic acids selected in vitro can catalyze a broad range of reactions even in the absence of proteins.

Catalysts, Nucleic Acids

Similar abstracts:

• Abstracts: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Alteration of Cre recombinase site specificity by substrate-linked protein evolution
• Abstracts: A decade of corporate women: some progress in the boardroom, none in the executive suite. International experience in the executive suite: the path to prosperity?
• Abstracts: Identification of in vivo DNA targets of chromatin proteins using tethered Dam methyltransferase. Aptamers on the scaffold
• Abstracts: Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Structural genomics and its importance for gene function analysis

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.